Samarth Kulkarni sold $202K of CRISPR Therapeutics stock
By AlphaYouPublished Form 4
Kulkarni Samarth
Reporting filer
Samarth Kulkarni reported selling 4,098 shares of CRISPR Therapeutics AG for about $202K ($49.26 a share on average). Form 4 filed Oct 15, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 15, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Kulkarni Samarth | 2026-10-13 | M | Exercise or conversion | 8333 | Not stated (see footnotes) | 263,834 | 2 days | Filed terms
|
| Common Shares | Kulkarni Samarth | 2026-10-14 | S | Sale | 4098 | 49.26 | 259,736 | 1 day | Filed terms
|
| Restricted Stock Units (derivative) | Kulkarni Samarth | 2026-10-13 | M | Exercise or conversion | 8333 | Not stated (see footnotes) | 0 | 2 days | Filed terms
|
Common Shares
- Owner
- Kulkarni Samarth
- Date
- 2026-10-13
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 8333
- Price
- Not stated (see footnotes)
- Following holdings
- 263,834
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-10-13
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 8333
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 263834
- direct Or Indirect Ownership: D
Common Shares
- Owner
- Kulkarni Samarth
- Date
- 2026-10-14
- Code
- S
- Action
- Sale
- Quantity
- 4098
- Price
- 49.26
- Following holdings
- 259,736
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-10-14
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Shares: 4098
- id: F2
- transaction Price Per Share: 49.26
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 259736
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Kulkarni Samarth
- Date
- 2026-10-13
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 8333
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F1
- transaction Date: 2026-10-13
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 8333
- id: F1
- transaction Acquired Disposed Code: D
- id: F3
- id: F3
- underlying Security Title: Common Shares
- underlying Security Shares: 8333
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kulkarni Samarth: Chief Executive Officer, Director.
- F1: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- F2: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- F3: This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.